»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ <:!:7
),2|TlQ
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 Ged} qXn
s\Ln
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£©
@
0%[4
1.Antigen presenting cell£¨APC£© :.(A,
2.Activation induced cell death£¨AICD£© pDcGf7
3.Chemokine pk6<wAs*?#
4.Major histocompatibility complex£¨MHC£© |Z8Eu0RSb
5.immunotolerance p[}~Z|(
,lVQ-qw5
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© gP>W* ]0r1
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ tD,I7%|@
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà CtZOIx.;|
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ v`U;.W
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ gw$?&[wY
5.±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌصã ~.z82m
>u]9(o7I
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© V5gr-^E
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ [kMWsiZ
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ 3mL(xpT.8z
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ Z6&bUZF$bE
Z:diM$Z?7
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ YD0j&
@.
*;Za))
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 O\h%ZLjfO
@.,'A[D!K
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ bD?gwhAKA
1.Antigenic determinant WkV0,_(P
2.IgSF . HAFKB;
3.MBL;¾¶ qHPinxewx
4.chemokine E:[!)UG|y
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ 1B$8<NCQ=?
6.TCR-CD3¸´ºÏÎï w}8=sw
7.FADD£¨Fas-associated protein with death domain£© Vddod
8.AIDS
(%G>TV
9.Tumor rejection antigen M XuHA?
10.AICD >y
$*|V}k
NOf{Xx<#k
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ fc4jbPp:M
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© Wxgs66
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ !/1~
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ Z=l2Po n
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì JB!*{{
%Rf{v5
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ #IeG/t(
'1zC|:,
N9vNSmm
רҵ¿Î ÃâÒßѧ ZI
c-^&`r=
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê )=5
*iWe
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell slLTZ]
5. Fc¦Å receptor 6. Cytokine Z*(OcQ-
¶þ¡¢ ÎÊ´ðÌâ QRF:6bAxsL
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØɱÉË°Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 yK mHTjX=
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ knWI7
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁÜ°ÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ v'Up& /(
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâЩÌصãµÄÉúÎïѧÒâÒ壿 \;+b1
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠ-CPLgT
D:(h^R0;
|+=ctpx9&
ePxf.U
}~#qDrK
!DKl:8mx4
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ W#^p%?8pR
sZokiFJ
d"+ _`d=`
רҵ¿Î ÃâÒßѧ
`?T8NK
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê ]O~/k~f
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen hiaTJE|J?
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin RP wP4Z
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test *Oy%($'
9. Hybridoma technic 10.Mitogen 11JO [
11.Dentritic cell 12.Immunoproliferation 9(BB>o54r
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ eBW]hwhKzM
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨Äļ¸¸öÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ tNW0 C]
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦ÓᣠopCQ=G1
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ 'RCX6TKBnR
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ l3kBt-m
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ m RtE~~p
@wXo{p@W
R=HcSRTkA
jyjK~!0
hC2Ra "te)
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ \"A~ks~
v>mr
o=doL{#
רҵ¿Î ÃâÒßѧ c::Vh
Ò»¡¢ Ãû´Ê½âÊÍ g ??@~\Ov
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï Q,xKi|$r
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà w
1|YR
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ "@E(}z'sM
¶þ¡¢ ÎÊ´ðÌâ nc%ly *
1¡¢ TÁÜ°Íϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ d/:zO4v3
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁÜ°Íϸ°ûºÍЧӦÎïÖÊ¡£ Flzl,3rW4
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆ乲ͬÌص㼰ÓëÁÙ´²µÄ¹Øϵ¡£ slMWk;fmD}
4¡¢ ºÎνÁÜ°Íϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ n~k9Z^ $
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØϵͳ£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ KBo/GBD]|
G>0
S(M)
C vtG
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Q2[D|{Z
niV= Ijt{5
NPM}w!
רҵ¿Î ÃâÒßѧ ;yO7!{_
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê 2*K _RMr~
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR ggUJ -M'2h
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA c91rc>
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM S5Q$dAL
¶þ¡¢ ÎÊ´ðÌâ cM;&$IjCt
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌص㡣 "$tP>PO{<
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ 'o2x7~C@
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖƵÄÒìͬµã¡£ bb6J$NR
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆ书ÄÜ¡£ b"y][5VE
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ 4#Fz!Km
AopCxaJ`
sW B;?7P
?+S& `%?
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ N6Fj}m&E
I%43rdoPe
!+4}x;!8
רҵ¿Î ÃâÒßѧ ->x+ p"
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê EAcJ>
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule 'g8~539{&
5. Autogous mixed lymphoyte reaction ^.F@yo2}
¶þ¡¢ ÎÊ´ðÌâ Cd.pMoS
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ <L@0w8i`
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ pO$`(+q[
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠo_p//S#q
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹Øϵ£¿ 4^V Y
EN()dCQHr
~wIVw}
dRyK'Xr
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ L$h.VQv+
`~[zIq:}7
k/O|ia6
רҵ¿Î ÃâÒßѧ =M)>w4-
QfB \h[A
/yyed{q
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê g1L$+xD^
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance IP$^)t[
5. Delayed type hypersensitivity Z:09]
r1
¶þ¡¢ ÎÊ´ðÌâ <P ~+H>;
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ :#"gQ^YNp
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ 9M:wUYHT
3. ¼òÊöHLAÓëҽѧµÄ¹Øϵ¡£ Z&@X4X"q
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ]<A|GY0q1
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óᣠ}]N7CWy
`#A&v
/}-]n81m
aAF:nyV~~0
x"K<@mR5G
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ,Ww)>O+
`+1+0?9
s\1h=V)!H
רҵ¿Î ÃâÒßѧ G/J5 aj[
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê ez&v"J
1. hypersensitivity 2. cluster of differentiation }H!c9Y
3. adhesion molecules 4. supper antigen 5. split tolerance Cy4@\X%W
¶þ¡¢ ÎÊ´ðÌâ f{FW7T}O2
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ r#JE7uneT
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ 1T!b#x4
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ hU3c;6]3
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ (BEGt'7
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ _(5SiK R
B BbGq8p
Xa=oryDt
^Wo/vm*]
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ I?uU}NK
רҵ¿Î ÃâÒßѧ Z,)4(#b =
Ò»¡¢ Ãû´Ê½âÊÍ 9+nB;vA
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å M(KsLu1
5. GVHR ztTj2M"
¶þ¡¢ ÎÊ´ðÌâ de1cl<
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óá£
&a5UQ>
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌصãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ Q^prHn*@
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌص㡣 83K)j"!<X
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ :7UC=GKQk
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ nNz1gV:0X
fqrQ1{%UH
fb-Lp#!T39
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ U;`C%vHff
U{i xok
Rd'P\
רҵ¿Î ÃâÒßѧ %jk7JDvl
Ò»¡¢Ãû´Ê½âÊÍ eyW8?:
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å p 4_j>JPv5
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ !C\$=\$
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ F
t/yPv
11. »ìºÏÁÜ°Íϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ GWFF.Mo^
Èý¡¢ ÎÊ´ðÌâ G0#<SJ,)
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ Z$?(~ln
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ >~@O\n-t
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà 37apOK4+
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ &Va="HNKt
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ srPczVG*
c wNJ{S+
-pmb-#`M
b?{MXJ|
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ n6AA%? 5
"I3
#/~q
H;nEU@>"Z
רҵ¿Î ÃâÒßѧ @E 8P>kq
Ò»¡¢Ãû´Ê½âÊÍ \sMe2OL#z
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó Y5CDdn
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁÜ°Íϸ°ûµÄ±íÃæ±êÖ¾ i0:1+^3^U
Èý¡¢ ÎÊ´ðÌâ },n?
1. ¼òÊöTÁÜ°Íϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ NSa6\.W)
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ 5U-SIG*
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ gw!d[{#
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ ,ZghV1z
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ Oa2\\I
5(gWK{R)*
SRtw
c]h@<wnv
o$eo\X?J?
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ LSo*JO6
Ò»¡¢Ãû´Ê½âÊÍ "fr{:'HX
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï nK32or3
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó j+fib} 8}
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ MVnN0K4
¶þ¡¢ ÎÊ´ðÌâ _RzFh
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ P1AC2<H
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ d<+hQ\BF,
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ ; >>n#8`
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ 9/!1J
K-~g IlbQ`
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ CIz0Gjtx6m
Ò»¡¢ Ãû´Ê½âÊÍ F)KR8(
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ 5[g\.yi2_]
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ }NoP(&ebz*
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© SkMFJ?J/
10¡¢ ÒõÐÔÑ¡Ôñ ~uH_y-
¶þ¡¢ ÎÊ´ðÌâ 6F!B*lr
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 2mnAL#
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ M,S'4Szuk
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 /zt M'
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ R2n
2mQ <
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. +^lB"OcOX@
iX6>u4~(
>xabn*Kq
7
jIBE
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ,#UZp\zZ*
t$z[ja=
K\rQb
רҵ¿Î ÃâÒßѧ 1'\QD`M9^
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ RC/ 3\'
1. Cytokines 2. adhesion molecules 3. graft versus host reaction Bj1%}B
4. immunologic tolerance 5. Opsonization !Fp %2gt|
Èý¡¢ ÎÊ´ðÌâ 0o=HOCL\
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠzo(#tQ-'m
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ 4MzQH-U>/
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ qK a}O*
4. ÃâÒßϵͳɱÉË°Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ t` "m@
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ cdt9hH`Cd
Bz/Vzc(
f\<r1
d
fj23+
}_]AQN$'G
qh~bX
i!
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ v.Ba
wQ/* f9
= ^NvUrK
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ z%YNZ^d
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ R ZY=c
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê f+^6.%
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ 8%7%[WC#
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û _6NUtU
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö fHup&|.
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð )hZ7`"f,ZN
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖƱ¸ÔÀí¡£ 5?k5J\+
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ zuvPV{
X
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃ濹ԺͱíÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© fjRVYOG#
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ AHb_B gOU*
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ i.Rl&t
qVn<c,8#
N(&{~*YE
QH/py
.EKlw##
x0
)V
o]r
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ ( C!p2f
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ #rlgeHG!fs
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ lMFR_g?r
*
65/gG8>
Ò»¡¢ Ãû´Ê½âÊÍ {[H_Vl@
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß g&$=Y7G
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò _?c.m*)A
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô *()['c#CC
¶þ¡¢ÎÊ´ðÌâ QQl.5'PP
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ V:n0BlZ,B
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì 0?7yM:!l
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì S<nF>JRJa
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ t1']q"
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ N<)CG,/w[M
'UhoKb_p